Patent · US Active

Spiropiperidine derivatives as NK3 antagonists

US7470684B2 · kind B2 · utility

3Cited by

0References

31Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Joanie Marie Caroon · Mountain View, US
Michael Patrick Dillon · Mill Valley, US
Bo Han · Shanghai, CN
Matthias Nettekoven · Weil am Rhein, DE
Hasane Ratni · Habsheim, FR
Walter Vifian · Gelterkinden, CH

Key dates

Filing date	Dec 20, 2007
Grant date	Dec 30, 2008
Priority date	—
Expiry date	Dec 20, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula Iwherein R1, R2, R3, R4, R7, m and n are as defined herein. These compounds are high potential NK-3 receptor antagonists useful for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.